Physician profile
Kerry Graebe
NPI 1053742262
$5,912.30
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,055 · 2020: $2,535 · 2021: $13.85 · 2023: $39.94 · 2024: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $5,250.00 | 2019-2020 | |
| Organon LLC | $268.56 | 2024 | |
| Exeltis, USA INC. | $62.82 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $56.36 | 2019-2020 | |
| Therapeuticsmd, INC. | $53.37 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $39.94 | 2023 | Exparel |
| Avion Pharmaceuticals | $29.53 | 2019 | |
| Abbvie INC. | $28.53 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $24.50 | 2019 | |
| Aspira Women'S Health INC | $16.49 | 2020 | |
| Daiichi Sankyo INC. | $14.76 | 2020 | |
| Duchesnay USA Incorporated | $14.75 | 2019 | |
| Lupin INC. | $13.85 | 2019 | |
| Pfizer INC. | $12.98 | 2019 | |
| Millicent US INC | $12.96 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Graebe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.